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INTRODUCTION Weiss, 1995; Erpel and Courtneidge, 1995). Members of
the Src family of tyrosine kinases are membrane-associ-
Replication of viruses depends on a plethora of
ated and act as transducers of signals emanating from
highly specific interactions with the host cell resulting
plasma membrane receptors, like, e.g., the PDGF recep-
in the subversion of multiple cellular signal transduc-
tor (Kypta et al., 1990) or the B and T cell receptors
tion pathways. Cell cycle progression, intracellular
(reviewed in Rudd et al., 1993). The activity of Src kinases
protein transport, and protein and nucleotide metabo-
is regulated by intramolecular interaction between a car-lism are among the many cellular processes deregu-
boxy-terminal phosphorylated tyrosine residue and thelated by viral proteins in order to establish a cellular
SH2 (Src homology 2) domain located in the amino-termi-environment favorable for virus replication. Viruses
nal half of the molecule (Liu et al., 1993) (Fig. 1). When thealso modulate a host’s immune response to escape
SH2 domain is engaged in binding the carboxy-terminalimmunosurveillance. Many of the pathways controlling
phosphotyrosine, the kinase is inactive. The SH3 (Srccell behavior are tightly regulated by cellular tyrosine
homology 3) domain immediately adjacent to the SH2kinases. One particular family of these enzymes, Src
domain is capable of binding proline-rich peptides andfamily kinases, are involved in processing signals ema-
seems to further stabilize the closed conformation of Src-nating from the plasma membrane. Two families of
related kinases perhaps upon binding to the catalytic orDNA viruses, polyoma- and herpesviruses, encode
SH1 (Src homology 1) domain (Abrams and Zhao, 1995;proteins targeted at tyrosine kinases. Middle-T anti-
Seidel-Dugan et al., 1992). Alternatively, the SH3, to-gens expressed by mouse and hamster polyomavirus
gether with the SH2 domain and the tail, might be in-associate with and activate Src family tyrosine kinases,
volved in dimerization of Src kinases. This model waswhile two members of the herpes family of DNA vi-
suggested by a crystal structure of the covalently linkedruses, Epstein – Barr virus (EBV) and herpesvirus saim-
SH3 and SH2 domains of Lck complexed with the tailiri (HVS), encode proteins, LMP2A and Tip, respec-
peptide (Eck et al., 1994). Src-related tyrosine kinases aretively, that associate with cellular tyrosine kinases of
activated by upstream signaling molecules that appearthe Src and Syk/Zap family. All four viral proteins tightly
to weaken the intramolecular interaction between thebind these kinases resulting in altered enzymatic activ-
regulatory tyrosine residue and the SH2 domain. Dephos-ity and changes in downstream signaling. In this re-
phorylation of this tyrosine residue by cellular phospha-view we focus on the mechanisms involved in the de-
tases might stabilize the open, active conformation. Acti-regulation of tyrosine kinases by viral proteins and
vation results in the phosphorylation of substrates down-discuss their possible function in virus replication and
stream in the signaling cascade, triggering interactionsspreading and in virus-induced tumorigenesis.
with a variety of cellular proteins.
Polyoma- as well as some herpesviruses encode pro-VIRAL PROTEINS ASSOCIATING WITH CELLULAR
teins capable of deregulating Src-related tyrosine ki-TYROSINE KINASES
nases. Four viral proteins have been identified so far:
Tyrosine kinases play a pivotal role in cell signaling mouse polyomavirus middle-T antigen (mouse middle-T)
regulating cell growth, differentiation, and morphology associates with three Src-related kinases, c-Src (Bolen
(reviewed in Taylor and Shalloway, 1996; Howe and et al., 1984; Courtneidge and Smith, 1983, 1984), c-Yes
(Kornbluth et al., 1987), and Fyn (Cheng et al., 1988a;
Kypta et al., 1988; Horak et al., 1989), resulting in the1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 61 697 3976. E-mail: ballmer@fmi.ch. activation of the former two, while hamster polyomavirus
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middle-T (hamster middle-T) associates with and acti- dle-T associates with one of the SH2 domains of the
regulatory 85-kDa subunit of phosphatidylinositol 3-ki-vates only Fyn (Courtneidge et al., 1991). Lymphocytes
persistently infected with Epstein–Barr virus (EBV) ex- nase (PI 3-kinase) through phosphorylated tyrosine 315
leading to the activation of the catalytic p110 subunit,press a viral protein, LMP2A, that associates with Src
family kinases, mainly Fyn and Lyn, and with the tyrosine which gives rise to the production of 3* phosphorylated
phosphatidylinositides (Whitman et al., 1985). Phospholi-kinase Syk (Miller et al., 1995; Burkhardt et al., 1992;
Longnecker et al., 1991). Finally, herpesvirus saimiri sub- pase C-g1 (PLC-g1) binds phosphorylated tyrosine 322
via an SH2 domain, presumably resulting in stimulationgroups 484 and 488 contain open reading frames, ORF2
and ORF1, respectively, which give rise to highly related of enzyme activity and the generation of diacylglycerol
and inositol triphosphate (Su et al., 1995). The adapterproteins associating with Lck, a Src family kinase pre-
dominantly expressed in lymphocytes (Lund et al., 1996; protein SHC, which contains an SH2 domain, a PTB do-
main, and a collagen-homologous region and activatesBiesinger et al., 1995). The HVS-C488-encoded polypep-
tide is also called Tip, for ‘‘tyrosine kinase interacting the Ras/MAP kinase pathway, associates with tyrosine
250 in the context NPTY via its PTB domain (Campbellprotein’’ (Biesinger et al., 1995).
Interestingly, neither adeno- nor papillomaviruses, et al., 1994; Dilworth et al., 1994). Hamster middle-T con-
tains two residues, tyrosines 298 and 330, that are puta-both distantly related to polyomaviruses, seem to ex-
press proteins capable of directly associating with and tive binding sites for PI 3-kinase and PLC-g1, respec-
tively (Courtneidge et al., 1991; Brizuela et al., 1995), yetthereby altering the function of Src-related kinases. How-
ever, both viruses express proteins, adeno E3 and papil- lacks a SHC binding site (Table 1).
Both middle-T’s contain several proline-rich se-loma E5, respectively, targeted at tyrosine kinase growth
factor receptors, like the EGF and PDGF receptors quences that might bind signaling molecules carrying
SH3 domains, but experimental evidence in support of(Straight et al., 1993; Kuivinen et al., 1993; Goldstein et
al., 1992; Carlin et al., 1989; Hoffman et al., 1992). These this idea is still missing. Mouse middle-T also associates
with members of the 14-3-3 family of proteins, whichreceptors have been shown to associate with and acti-
vate Src-related kinases like c-Src and Fyn upon stimula- are suggested to act as scaffolding proteins during the
formation of protein complexes (Pallas et al., 1994). Fi-tion by their ligands (reviewed in Courtneidge et al.,
1993). E3 and E5 might therefore indirectly influence the nally, phosphatase 2A (PP2A) has been shown to bind
the amino-terminal domain of mouse and hamster mid-activity of Src-related kinases complexed with tyrosine
kinase growth factor receptors. dle-T which is shared with small-T, resulting in altered
in vitro substrate specificity of this enzyme (Cayla et al.,
1993; Ruediger et al., 1994; Yang et al., 1991; Scheidt-THE MIDDLE-T ANTIGENS OF POLYOMAVIRUSES
mann et al., 1991; Campbell et al., 1995; Pallas et al.,
1990) (Table 1). Association of PP2A with mouse middle-Upon alternative splicing of the primary early tran-
script, polyomaviruses produce three mRNA’s encoding T and small-T has been studied in detail and the epitopes
involved are well defined (Campbell et al., 1995; Mungrethe tumor antigens, large-, middle-, and small-T (Tooze,
1980). Mouse middle-T and hamster middle-T are 55% et al., 1994; Ruediger et al., 1992).
identical within the amino-terminal domain which is
shared by large- and small-T antigens. Except for the fact MECHANISM OF ASSOCIATION OF MOUSE AND
that both proteins have a carboxy-terminal membrane HAMSTER MIDDLE-T WITH Src-RELATED KINASES
anchor, very little homology is detected in the middle-T-
specific unique domains. Expression of mouse middle-T The mechanisms responsible for association of mouse
and hamster middle-T with Src-related tyrosine kinasesresults in a 5- to 10-fold increase in overall c-Src (Bolen
et al., 1984; Courtneidge and Smith, 1984) or c-Yes (Korn- are distinct. Earlier work gave conflicting results sug-
gesting either the carboxy-terminal (Cheng et al., 1988b)bluth et al., 1987) kinase activity, while Fyn is not acti-
vated (Horak et al., 1989). However, no concomitant in- or amino-terminal domains of c-Src to be responsible for
association with mouse middle-T (Louie et al., 1988). Wecrease in overall tyrosine phosphorylation of cellular pro-
teins is observed in middle-T-transformed cultured cells. have shown recently that mouse middle-T associates
with Src kinase mutants lacking all domains amino-termi-Hamster middle-T, on the other hand, exclusively associ-
ates with Fyn which is activated about 2-fold (Court- nal to the catalytic (SH1) domain (Dunant et al., 1996).
When c-Src was truncated after residue 518, mouse mid-neidge et al., 1991).
Both middle-T’s contain a series of tyrosine residues dle-T was not phosphorylated anymore in vitro (Cheng
et al., 1988b), yet defective complexes could be detectedin their unique domains that are phosphorylated upon
association with Src-related tyrosine kinases and are in metabolically labeled cells (Dunant et al., unpub-
lished). This suggests that proper positioning of mouserequired for binding cellular signaling molecules via SH2
(reviewed in Pawson, 1994) or PTB (reviewed in van der middle-T relative to the catalytic domain of c-Src is dic-
tated by the c-Src tail.Geer and Pawson, 1995) domains (Table 1). Mouse mid-
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TABLE 1
Synopsis of Viral Proteins Associating with Src-Related and Syk/Zap Family Kinases
Additional signaling
Viral protein Kinases bound Binding mechanism for tyrosine kinases proteins bound
Mouse middle-T c-Src, c-Yes, Fyn Association with SH1 domain PP2A, PI 3-K, SHC, PLC-g1, 14-3-3
Hamster middle-T Fyn Association with SH2 domain via pYEEI motif PP2A, PI 3-K, PLC-g1
LMP2A Syk, Zap Association with SH2 domain via pYXXLN7pYXXL motif PI 3-K, PLC-g2, Vav
Lyn Association with SH2 domain via pYEEA motif
Tip Lck Association with SH3 domain via proline-rich SH3B domain;
CSKH domain also required
Note. In the case of LMP2A, association with tyrosine kinases is well established, while binding to signaling molecules is speculative and has
not been shown experimentally so far.
The interaction between c-Src and mouse middle-T is bind the SH2 domains of Src-related kinases, as deter-
mined in a phosphopeptide library screen (Songyang etnot stoichiometric. Ten to 15% of mouse middle-T are
engaged in binding wt c-Src and only 10% of c-Src are al., 1993). Based on the finding that a Fyn mutant lacking
the SH2 domain did not bind hamster middle-T, we mu-bound to mouse middle-T (Bolen et al., 1987; Cheng et
al., 1990). However, stoichiometric complexes are formed tated tyrosine 324 to phenylalanine. The mutant protein
showed threefold reduced association with Fyn (Dunantwith activated Src kinase mutants lacking either the SH2
or the SH3 domain (Dunant et al., 1996). These mutants et al., in press). Residual association with Fyn is most
likely due to phosphotyrosine-independent binding.are believed to assume an open conformation resulting
in increased association with mouse middle-T. The Moreover, the same study showed that this mutation
abolished the oncogenicity of hamster middle-T. There-mechanism by which mouse middle-T activates Src ki-
nases might therefore be to stabilize activated molecules fore, phosphorylation of hamster middle-T at tyrosine
324, most likely by Fyn itself, is essential to form a func-present in the open conformation (Fig. 1). We hypothesize
that intermolecular interaction between mouse middle-T tional complex with Fyn. This is in contrast to mouse
middle-T, where none of the tyrosine residues is requiredand c-Src or c-Yes prevents an intramolecular interaction
between the regulatory phosphotyrosine and the SH2 for c-Src binding. It has also been shown that even cata-
lytically inactive c-Src associates with mouse middle-Tdomain in these enzymes, resulting in constitutive activa-
tion of mouse middle-T-associated c-Src and c-Yes. This (Cheng et al., 1990).
The question remains why mouse middle-T binds c-is in agreement with the earlier finding that c-Src associ-
ated with mouse middle-T is dephosphorylated at tyro- Src, c-Yes, and Fyn, while hamster middle-T associates
only with Fyn. The most likely concept is that mousesine 527 (Cartwright et al., 1986; Courtneidge, 1985).
It has been more difficult to define epitope(s) present middle-T associates with epitopes well conserved in the
SH1 domain of these kinases, but not in other Src familyin mouse middle-T that are required for c-Src binding. A
comprehensive mutational analysis suggests that even members like Lck or Lyn. In the case of hamster middle-
T, it is likely that other regions, besides the YEEI motif,minor changes in the amino-terminal domain of mouse
middle-T, which is also responsible for PP2A binding, are responsible for determining specificity of the interac-
tion with Fyn since this motif has been shown to tightlyblock association with c-Src (Cheng et al., 1989; Mark-
land and Smith, 1987; Campbell et al., 1995). Recent evi- bind the SH2 domain of several Src family members
(Songyang et al., 1993).dence suggests that PP2A association with mouse mid-
dle-T is essential for c-Src binding and indicates that
structural determinants present in PP2A might take part LMP2 AND Tip OF HERPESVIRUSES
in the formation of a ternary complex (Glenn and Eckhart,
1995). An alternative interpretation of these data is that Two classes of herpesviruses, a human virus, EBV,
and HVS endemic in a new world monkey, have beenthe phosphorylation state of mouse middle-T is tightly
regulated by PP2A and determines its ability to associate shown to target Src kinases by LMP2 and Tip, respec-
tively. Both viruses are tumorigenic. EBV is associatedwith c-Src. An epitope required to bind c-Src, but not
PP2A, has been located between amino acids 203 and with Burkitt’s lymphoma while in the case of HVS, tumors
arise when the virus infects different highly related mon-240 of mouse middle-T using T antigen-specific mono-
clonal antibodies (Dilworth and Horner, 1993). key species.
LMP2 exists in two splice variants, LMP2A and LMP2B,In contrast to mouse middle-T, hamster middle-T car-
ries a stretch of amino acids, YEEI (tyrosine in position which are both membrane-associated and differ in their
amino-terminal domains. LMP2A associates with Src-re-324), corresponding to the optimal sequence known to
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lated kinases (Longnecker et al., 1991; Burkhardt et al., and leukemia (Scherneck and Feunteun, 1990; Tooze,
1980). Polyomavirus large-T antigen is essential for viral1992) and a 72-kDa tyrosine kinase which is probably
Syk (Miller et al., 1994a, 1995). These interactions might DNA replication and capable of immortalizing cells (re-
viewed in Pipas, 1992). The middle-T antigens of mousebe mediated by tyrosine peptide sequences present in
the amino-terminal domain of LMP2A that have also been and hamster polyomaviruses show low sequence homol-
ogy in their unique domains, although these viruses arefound in cellular signaling molecules. A motif pYEEA
known to bind Src family SH2 domains in vitro (Songyang highly homologous in genome structure, clearly setting
them apart from the related monkey and human viruseset al., 1993) might recruit Fyn or Lyn to LMP2A. Syk/Zap
tyrosine kinases might associate with LMP2A through that all lack the middle-T reading frame (Delmas et al.,
1985; Tooze, 1980). The unique domain of middle-T isa sequence pYXXLN7pYXXL that is known to mediate
association of these kinases with the phosphorylated T encoded in an area of the genome that is poorly con-
served among the SV40 (SV40, BK, JC) and the polyomacell receptor z chain (Weiss, 1993; Beaufils et al., 1993).
The fact that LMP2A can block B lymphocyte signaling group of papovaviruses (Tooze, 1980). In SV40-like vi-
ruses, this region encodes the large-T epitope capablethrough the surface immunoglobulin (sIg) receptor (Miller
et al., 1994a,b) is probably the consequence of seques- of binding p53, the ‘‘guardian of the genome’’ (reviewed
in Lane and Benchimol, 1990; Pipas, 1992). This resultstering both Lyn and Syk into complexes with LMP2A
that act as dominant negative constituents in the B cell in inactivation of the cell cycle surveillance function of
p53 and might prevent virus-induced apoptosis. Mousereceptor signaling cascade (Miller et al., 1995). The
pYXXLN7pYXXL peptide has also been shown to be func- and hamster polyomaviruses express large-T antigens
that do not bind p53, and one might therefore speculatetional in a chimeric protein consisting of the extracellular
and transmembrane domain of the CD8 receptor and the that polyomaviruses inactivate or subvert the function of
p53 or some of its downstream targets through middle-cytoplasmic domain of the bovine leukemia virus enve-
lope protein gp30 (Beaufils et al., 1993). The chimeric T antigen. In this case, though, a completely different
mechanism than employed by SV40 large-T must be envi-protein elicited early and late events required for lympho-
cyte activation and has been shown to give rise to B cell sioned. It will be interesting to study whether middle-
T-induced pathways, in particular the Ras/MAP kinaseproliferation. To initiate association with tyrosine ki-
nases, LMP2A must be phosphorylated at the specific cascade, and the functions altered in SV40-transformed
cells as a consequence of sequestering p53 into large-tyrosine residues mentioned above. It is not yet clear
how this is brought about, but phosphorylation by Src T complexes converge on any of the known cell cycle
regulatory proteins, like, e.g., cyclin-dependent kinasekinases, e.g., Lck, upon stimulation through ancillary sub-
units of the B cell receptor complex seems to be a likely inhibitors, cyclins, or cdk’s (reviewed in Eick and Hermek-
ing, 1994; Cox and Lane, 1995).explanation.
Tip of HVS strain C488 is composed of a series of The middle-T antigens of polyomaviruses have been
shown to be required for virus-induced oncogenesis andpeptide motifs that are all required for binding to Lck: a
38-amino-acid peptide called the CSKH domain which cell transformation in vitro. Transgenic animals express-
ing mouse middle-T show endotheliomas, while hamsteris related to a sequence present close to the carboxy-
terminus of the kinase domain of all Src-related kinases, middle-T causes mainly skin epitheliomas and
lymphoma (reviewed in Kiefer et al., 1994b). This is aa proline-rich motif called SH3B, and a spacer linking
these domains (Jung et al., 1995a) (Fig. 2). The SH3 do- consequence of the activation of a variety of cellular
signaling proteins regulating cell growth. Phosphoryla-main of Lck is sufficient for Tip binding (Jung et al., 1995b)
and none of the other Src-related kinases seems to asso- tion of middle-T by Src-related kinases at specific tyro-
sine residues is essential to assemble these cellularciate with Tip (Wiese et al., 1996). A hydrophobic se-
quence at the carboxy-terminus of Tip probably localizes proteins into an active signaling complex (reviewed in
Dilworth, 1995). The ability of mouse middle-T to inducethis protein to cellular membranes but seems not to be
required for interaction with Lck. Membrane-bound Tip tumors has also been analyzed in gene knockout mice
lacking c-Src, c-Yes, or Fyn (Thomas et al., 1993; Kiefermight interfere with lymphocyte-specific early signaling
events localized at the plasma membrane. et al., 1994b). These studies showed that expression of
only two of the kinases known to associate with mouse
middle-T is sufficient for endothelioma formation. In con-WHAT IS THE ROLE OF MIDDLE-T IN THE
trast to c-src and fyn knockout animals, c-yes-deficientPOLYOMAVIRUS LIFE CYCLE AND IN
mice showed a reduced number of tumors and a longerVIRUS-MEDIATED ONCOGENICITY?
latency period (Kiefer et al., 1994a), suggesting that the
contribution of c-Yes in tumor formation is only partiallyPolyomaviruses were originally discovered as agents
causing tumors in mice and hamsters. The mouse virus compensated by other Src family kinases. Hamster mid-
dle-T was still able to transform endothelial cells fromusually induces tumors derived from mesenchymal cells,
while the hamster virus causes epitheliomas, lymphoma, fyn knockout mice (Kiefer et al., 1994b). This suggests
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FIG. 2. Domain structure of viral proteins associating with Src family kinases. Epitope assigned to PP2A binding site of the middle-T’s is tentative
and derived from mutants made in SV40 small-T and mouse middle-T (Campbell et al., 1995; Mungre et al., 1994). Dark gray boxes indicate
transmembrane domains.
that another, not yet identified tyrosine kinase might com- portant to note that peptides derived from polyomavirus
T antigens act as tumor-specific transplantation antigenspensate for the lack of Fyn or that kinase activity in the
hamster middle-T complex is dispensable for transforma- (TSTA) and play a role in eliciting an immune response
to polyomavirus-induced tumor cells (Reinholdsson Ljun-tion of this cell type.
Studies performed with mouse polyomavirus in tissue ggren et al., 1992; reviewed in Dalianis, 1990).
A role for mouse middle-T in activating the Ras/MAPculture cells showed that mouse middle-T is also re-
quired for virus replication (Garcea et al., 1989). Mutants kinase signaling cascade has been proposed in virus-
mediated S phase induction (Urich et al., 1995; Srinivasof mouse middle-T that are only capable of binding PP2A
were sufficient to support virus growth in cell culture. et al., 1994). Immediate early genes induced through the
MAP kinase pathway are also expressed upon bindingIn vivo, however, these mutants were defective in virus
replication and unable to spread to secondary sites of of virus capsids to cell surface receptors (Zullo et al.,
1987). Virus mutants expressing a mouse middle-T un-replication (Freund et al., 1992). This study also showed
that tumor formation in animals requires an intact mouse able to bind Src kinases and to activate the MAP kinase
cascade in the absence of growth factors grow like wildmiddle-T and correlates with the ability of the virus to
maintain a persistent infection. In this context it is im- type in NIH 3T3 cells in serum-containing medium (Gar-
AID VY 8316 / 6a22$$$281 12-31-96 09:48:41 vira AP: Virology
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cea et al., 1989). These middle-T mutants that still associ- the kinase from phosphorylating cellular targets. Binding
of Tip to the SH3 domain might also block the interactionate with PP2A might cooperate with small-T in preventing
downregulation of growth factor-induced MAP kinase ac- of Lck with specific cellular targets. One of the biological
consequences of Tip-induced Lck inactivation in lympho-tivity as reported for SV40 small-T (Frost et al., 1994;
Sontag et al., 1993). The mitogenic function of mouse cytes is downregulation of surface antigens like CD2 and
CD4 (Jung et al., 1995b). This is reminiscent of the effectsmiddle-T might therefore be required when a virus repli-
cates in cells grown in low serum or in low multiplicity observed in Lck knockout mice (Molina et al., 1992), sug-
gesting that active signaling through Lck is required forinfections.
The function of mouse middle-T during virus replica- expression of T cell-specific surface antigens. A recent
study shows that Tip can activate Lck in some T cellstion is, at least in part, to increase the efficiency of virus
encapsidation late in the replicative cycle (Garcea et al., as well as in in vitro phosphorylation assays (Wiese et
al., 1996). This might be the consequence of differences1985, 1989; Garcea and Benjamin, 1983). To initiate en-
capsidation, the major coat protein, VP1, is phosphory- in the experimental system used by these authors.
A different virus strain, HVS 484-77, expresses a pro-lated at canonical MAP kinase phosphorylation sites,
suggesting that MAP kinase activated by mouse middle- tein highly related to Tip. Expression of this protein has
been associated with IL-2-independent growth of virus-T might phosphorylate VP1 in virus-infected cells (Li and
Garcea, 1994). infected T lymphocytes (Lund et al., 1996). Since Lck has
been shown to mediate signaling downstream from the
IL-2 receptor (Hatakeyama et al., 1991), it is tempting toWHAT IS THE ROLE OF LMP2A AND Tip IN
speculate that Tip of HVS 484-77 functions in activatingHERPESVIRUS PROPAGATION AND
this pathway in a ligand-independent way. This mightONCOGENICITY?
confer HVS-infected and immortalized cells with a factor-
independent growth phenotype.In vivo LMP2A is expressed in latently infected B lym-
phocytes and nasopharyngeal carcinoma cells (Qu and
Rowe, 1992; Busson et al., 1992; Brooks et al., 1992). This EVOLUTION OF VIRAL PROTEINS TARGETING
CELLULAR TYROSINE KINASESled to the suggestion that LMP2A plays a crucial role in
establishing virus persistence in EBV-infected patients.
Considering the various strategies that polyoma- and
Lytic reactivation of EBV has also been shown to be
herpesviruses use to target cellular tyrosine kinases
blocked in LMP2A-expressing lymphocytes in cell culture
raises the question of how the middle-T antigens,
(Miller et al., 1994a,b). As described above, LMP2A mod-
LMP2A, and Tip evolved. A direct relationship with ances-
ulates cell signaling downstream of the sIg cell surface
tral cellular genes has not been found so far, yet many
receptor in persistently infected B cells blocking the ex-
of the motifs carried by these proteins are also present
pression of both cellular and viral genes that are essen-
in cellular proteins involved in cell signaling. Herpesvirus
tial for virus replication. LMP2A might thereby allow af-
reading frames encoding LMP2A and Tip show no appar-
flicted B lymphocytes to escape from immunosurveil-
ent sequence homology, although they are located at
lance. Epstein–Barr virus also transforms cells in vitro
similar positions in their respective viral genomes (Al-
and causes malignant growth in rare cases. Both LMP’s
brecht et al., 1992). Similarly, the reading frames coding
and a set of nuclear proteins, EBNA’s, might be involved
for the middle-T antigens of mouse and hamster poly-
in this process (reviewed in Kieff, 1996; Klein, 1994). How-
omavirus map to the same domain in the respective viral
ever, contrary to the polyomavirus middle-T antigens that
genomes yet are poorly conserved in the second, middle-
are highly oncogenic, LMP2A does not transform cells
T-specific exon. Therefore, targeting of tyrosine kinases
in culture as demonstrated using EBV mutants lacking a
by LMP2A, Tip, and the middle-T antigens is most likely
functional LMP2A reading frame (Longnecker et al., 1992,
the product of independent evolutionary processes. Se-
1993a,b).
quences encoding viral protein motifs capable of associ-
A similar function might be postulated for Tip in her-
ating with cellular tyrosine kinases might have been ac-
pesvirus saimiri-infected cells. Tip seems to cooperate
quired by recombination with host genes during virus
with STP during virus-mediated transformation and tumor
replication. Alternatively, the evolution of these motifs
formation in HVS-infected cells (Bro¨ker et al., 1993; Jung
might be the product of random mutations propagated
et al., 1991; Biesinger et al., 1992). Tip has been shown
as a consequence of increased viral fitness.
to attenuate the activity of Lck in fibroblasts transformed
with an activated Lck mutant and to reduce phosphoryla-
CONCLUSIONS
tion of substrates like calpactin I (Jung et al., 1995b). Tip
also blocks signaling through the T cell receptor and Both polyoma- and herpesviruses express proteins ca-
pable of targeting tyrosine kinases that regulate the cellu-prevents in vitro phosphorylation of substrates upon CD3
stimulation (Jung et al., 1995b). In HVS-infected cells, Tip lar signaling network. Similar to LMP2A in EBV-infected
cells, Tip and middle-T may cooperate with the immor-might be the primary substrate of Lck, thereby preventing
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